NCT04817891 - Stimulation of Cingulo-opercular Alertness Network | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

August 26, 2024

Study Completion Date

August 26, 2024

Conditions

Lewy Body DiseaseLewy Body Variant of Alzheimer DiseaseLewy Body Dementia With Behavioral Disturbance

Interventions

DEVICE

HD-tDCS

Participants will receive HD-tDCS at up to 4 mA per channel for 20 minutes for 10 sessions. Dose determined through individualized computational models.

Trial Locations (1)

48105

4250 Plymouth Road (University of Michigan), Ann Arbor

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Michigan

OTHER